Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-30 11:57:48 - browse：615

Layoff concept illustration of empty desks and people walking away. — Adobe

Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biology called biomolecular condensates, laid off 15% of its staff on Tuesday and acknowledged that a pair of collaboration deals with pharma companies had fallen apart.

The downsizing is temporary, CEO Ameet Nathwani told STAT. The company needed to hire new employees with expertise to help move the company’s first drugs into clinical trials and expand its AI capabilities. And with funding for early-stage biotechs still sparse, leadership opted to cut some positions and use the savings to fill new ones over the coming months. Roughly 20 positions were cut.

“We talked to investors right now [about raising more money], and they think that the environment for a preclinical company — it’s not even worth having that discussion,” Nathwani said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Personalized medicine goes far beyond genetics

WSS

Teach medical students about patients with intellectual disabilities

How to ethically and practically extend health care to all

SCOTUS to consider access to abortion pill mifepristone

Chris Christie meets with Zelenskyy during Ukraine trip

A controversial new treatment promises to make little people taller

Late stage cancers on the rise after pandemic delayed screenings

focus

Wikipedia

explore

Hollywood unions extend contract negotiations for actors

Chemotherapy shortages won’t get better under Biden’s latest plan

At least 13 dead in Texas as scorching temps continue

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

What does generative AI mean for health care? We asked experts

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

State Dept. review finds Biden bears some blame for Afghanistan failures

The woman behind the Dana Farber

ChatGPT in medicine: STAT answers readers' burning questions

FDA approves world's first CRISPR

explore

Alnylam reports growth in sales of rare disease treatments

SCOTUS to consider access to abortion pill mifepristone

What causes an itch? Researchers may have solved the mystery

Spinal cord stimulation reduces pain in amputees, study finds

Why sickle cell disease is getting the first CRISPR treatment

Chemotherapy shortages won’t get better under Biden’s latest plan

hotspot

focus

knowledge

focus